Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Aubry

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Healthplan|February 24, 2001
Bolstering disease management programsB Aubry
Economie & Statistique|July 1, 1988
[Interregional migration over the last 30 years: from attraction to indifference...and vice versa]B Aubry
Revue Medicale Suisse|March 30, 2012
[Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)]B Aubry-Rozier
Revue Medicale Suisse|February 7, 2008
[Rheumatoid arthritis and ankylosing spondylitis--rheumatologic highlights 2007]J Dudler, B Aubry-Rozier
Revue Medicale Suisse|March 29, 2013
[Connective tissue diseases: news in therapy, role of biologics agents]B Aubry-Rozier, I Fabreguet
Revue Medicale Suisse|November 29, 2012
[Therapeutic goal of vitamin D: optimal serum level and dose requirements]O Lamy, B Aubry-Rozier, D Stoll
AORN Journal|September 3, 1999
Moveable intraoperative magnetic resonance imaging systems in the ORP A Leblanc, B Aubry, M Gervin
La Revue De Medecine Interne|May 11, 2012
[Diffuse sclerosing osteomyelitis of the mandible and SAPHO]B Aubry-Rozier, A Basch, J Dudler
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 23, 2013
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fracturesO Lamy, B Uebelhart, B Aubry-Rozier
Revue Medicale Suisse|February 12, 2011
[Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations]M Faucherre, B Pazar, A So, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Healthplan|February 24, 2001
Bolstering disease management programsB Aubry
Economie & Statistique|July 1, 1988
[Interregional migration over the last 30 years: from attraction to indifference...and vice versa]B Aubry
Revue Medicale Suisse|March 30, 2012
[Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)]B Aubry-Rozier
Revue Medicale Suisse|February 7, 2008
[Rheumatoid arthritis and ankylosing spondylitis--rheumatologic highlights 2007]J Dudler, B Aubry-Rozier
Revue Medicale Suisse|March 29, 2013
[Connective tissue diseases: news in therapy, role of biologics agents]B Aubry-Rozier, I Fabreguet
Revue Medicale Suisse|November 29, 2012
[Therapeutic goal of vitamin D: optimal serum level and dose requirements]O Lamy, B Aubry-Rozier, D Stoll
AORN Journal|September 3, 1999
Moveable intraoperative magnetic resonance imaging systems in the ORP A Leblanc, B Aubry, M Gervin
La Revue De Medecine Interne|May 11, 2012
[Diffuse sclerosing osteomyelitis of the mandible and SAPHO]B Aubry-Rozier, A Basch, J Dudler
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 23, 2013
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fracturesO Lamy, B Uebelhart, B Aubry-Rozier
Revue Medicale Suisse|February 12, 2011
[Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations]M Faucherre, B Pazar, A So, et al.
Pageof 4